Overview

Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A multi-center and open study to compare the safety and effectiveness of switching treatment from lamivudine to clevudine for 24 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Bukwang Pharmaceutical
Treatments:
Clevudine
Lamivudine